<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">Results</a></li><li><a href="#id3">REASON FOR VISIT</a></li><li><a href="#id4">Medications</a></li><li><a href="#id5">Social History</a></li><li><a href="#id6">Vital Signs</a></li><li><a href="#id7">Encounters</a></li><li><a href="#id8">Assessments</a></li><li><a href="#id9">Plan Of Treatment</a></li><li><a href="#id10">Progress Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1"/><td>Codeine Phosphate</td><td ID="reaction1">nausea/vomiting</td><td>Drug Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">Results</a></h3><div><table width="100%" border="1"><thead><tr><th>Component</th><th>Value</th><th>Reference Range</th><th>Notes</th></tr></thead><tbody><tr><td colspan="4"><span class="content_span">ECG- COMPLETE (93000) IH</span><br/>Reviewed date:[REDACTED] 12:31:23 PM<br/>Interpretation:<br/>Performing Lab:<br/>Notes/Report:<br/></td></tr></tbody></table></div><h3><a name="id3" href="#toc">REASON FOR VISIT</a></h3><div>6 month f/u</div><h3><a name="id4" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Omeprazole 20 MG</td><td ID="instruction1"> Oral for 45</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Memantine HCl 10 MG</td><td ID="instruction2">TAKE ONE TABLET BY MOUTH TWICE A DAY Oral</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Venlafaxine HCl ER 75 MG</td><td ID="instruction3">TAKE THREE CAPSULES BY MOUTH EVERY MORNING Oral</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Trazodone HCl 100 MG</td><td ID="instruction4">TAKE ONE TABLET BY MOUTH ONE TIME DAILY Oral</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Midodrine HCl 2.5 MG</td><td ID="instruction5">1 tablet Orally Three times a day for 30 day(s)</td><td/><td>[REDACTED]</td><td/><td>Not-Taking</td></tr><tr><td ID="medication6">Atorvastatin Calcium 40 MG</td><td ID="instruction6">TAKE ONE TABLET BY MOUTH ONE TIME DAILY Oral</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Aripiprazole 2 MG</td><td ID="instruction7">TAKE ONE TABLET BY MOUTH ONE TIME DAILY Oral</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Celecoxib 100 MG</td><td ID="instruction8"> Oral for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">BuPROPion HCl ER (SR) 100 MG</td><td ID="instruction9">TAKE ONE TABLET BY MOUTH ONE TIME DAILY IN THE MORNING Oral</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Levothyroxine Sodium 88 MCG</td><td ID="instruction10">TAKE ONE TABLET BY MOUTH ONE TIME DAILY Oral</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Aspirin 81 81 MG</td><td ID="instruction11">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Former Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Tobacco Status:</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Patient is</td><td>a former smoker</td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Height</th><td>67 in</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Weight</th><td>144 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital3">BMI</th><td>22.55 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Blood pressure systolic</th><td>118 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Blood pressure diastolic</th><td>78 mm Hg</td><td>[REDACTED]</td></tr><tr><th ID="vital6">Heart Rate</th><td>72 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital7">Oximetry</th><td>97 </td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>343911NHM NW HEART HEALTH INST [REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Nonobstructive atherosclerosis of coronary artery I25.10</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Nonobstructive atherosclerosis of coronary artery (ICD-10 - I25.10)</td><td/><td> doing well, continue current management.</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Nonobstructive atherosclerosis of coronary artery</td><td> doing well, continue current management.</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 1 Year, Reason: </td></tr></tbody></table></div><h3><a name="id10" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] F) <span class="bold">Acc No.</span> 8X402661790 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">PROGRESS NOTE</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>8X402661790</td><td align="right"><span class="bold">Provider: </span>[REDACTED], MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>79 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td><td align="right"><span class="bold"> CHN#: </span>1174932495</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>[REDACTED]</td></tr>--&gt;    </tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   6 month f/u</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Patient History</span>: <br/>       <content>[REDACTED] female with PMH of non-obstructive CAD, COPD, HLD, orthostatic hypotension, hypothyroidism, arthritis, depression, presented for f/u. <br/>She was told to have 50-60% coronary obstruction per angiogram about [REDACTED]. She had stress test and TTE performed in [REDACTED], which showed low normal LVEF, no evidence of ischemia, no abnormality otherwise. <br/>[REDACTED] she reports she overall feels well. She is able to walk 5-7 miles a day without exertional dyspnea or angina. Denies any chest pain, significant SOB, palpitations, dizziness, syncope, orthopnea, le edema.  She is compliant with aspirin and statin.<br/>EKG by my read is unremarkable.<br/>---------------------------------------<br/>ECHO CONCLUSIONS: [REDACTED]<br/><br/>1. Normal wall thickness. Diastolic Function Normal diastolic parameters. Normal left<br/>ventricular size. Left ventricular systolic function appears low normal. LV Ejection<br/>Fraction is 50-55 %.<br/>2. Resting Segmental Wall Motion Analysis: There are no regional wall motion<br/>abnormalities.<br/>3. Normal right ventricular size. Normal right ventricular systolic function. RV systolic<br/>pressure of 31 mmHg. RV systolic pressure is at the upper limits of normal.<br/>4. No aortic valve stenosis. Trace aortic valve regurgitation.<br/>5. Mild mitral valve regurgitation.<br/>6. Mild tricuspid valve regurgitation.<br/>7. Normal pulmonic valve structure.<br/>------------------------------------------9.</content><br/>   <span class="Underline">Do Not Use                                         First Point of Contact Screening</span>: <br/>      Do you have any of the following symptoms? New symptoms over the past 7 days none, In the past 3 weeks, have you traveled either within [REDACTED] or internationally? No, In the past 3 weeks, have you had close contact with someone who has traveled either within [REDACTED] or internationally? No, Have you been in close contact with a person confirmed to have COVID-19? No, Actions taken by office staff reviewer No action, screening negative. <br/>       <content>last ekg 8/23<br/>-----------------------------------.</content></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">CARDIOLOGY</span>: <br/>      Constitutional: MsoNormal style="MARGIN: 0in 0in 0pt; LINE-HEIGHT: normal"&gt;<span class="content_span">14 point review of systems, pertinent positives noted, otherwise negative. </span><span class="content_span"/></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><br/><br/>
</body></html>